SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Short Candidates
An SI Board Since December 2000
Posts SubjectMarks Bans
897 95 0
Emcee:  tuck Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
622Peter, VHL-HIF correlation and connection can explain tumor activity from ati-Miljenko Zuanic-12/3/2003
621While the debate rages over ONXX, here's an AGEN abstract from ASH, which setuck-12/3/2003
620<i> so my concern is why 9006 is active for RCC and not for CRC</i> Biomaven-12/2/2003
619Tuck, <<Well, this is an interesting question. The degree of involvement oMiljenko Zuanic-12/2/2003
618The full text of this article might say exactly what % of RCCs overexpress MAP ktuck-12/2/2003
617>>I would like to know what were pts status (and genetic make up) at baseltuck-12/1/2003
616<< These were very sick patients, so the response they have gotten so far Miljenko Zuanic-12/1/2003
615TYGREENLAW4-7-12/1/2003
614<i>The most questionable aspect of this stock and its current 800 mil markBiomaven-12/1/2003
613Interesting, but do you mind telling me what trial you're talking about? Thtuck-12/1/2003
612not to mention they only have 5 employees. LOLgotmojo-11/30/2003
611Gomo, ONXX showed up on my alert list last week. I wrote a piece about the lack GREENLAW4-7-11/30/2003
610Check out ONXX. Making new highs w/out news and low volume. May start a positiongotmojo-11/30/2003
609Gen-Probe has been testing its all time highs after this news: >>SAN DIEGtuck-11/28/2003
608THE BSCP shorts a half position of MAXY for a quick swing trade at $10.50. It atuck-11/21/2003
607Yeah, but melanoma has responded to vaccine approach in other instances though nkeokalani'nui-11/12/2003
606From Briefing.com: >>12:02PM Vaxgen: Failure of AIDSVAX trial was widely tuck-11/12/2003
605This little item came out at noon ET, and allowed me to sell a few calls at my ttuck-11/12/2003
604Yeah, but their melanoma results looked pretty good. Whatever, BSCP maintains ituck-11/12/2003
603Agen has to be way up there as a short candidate. CMO quit/fired today (Lead drkeokalani'nui-11/3/2003
602I was just following Miljenko on that one. All credit goes to him: thanks, MZ! tuck-10/31/2003
601KA-CHING. Nice call; CV Therapeutics Shares Fall on U.S. FDA Letter About Ramopgcw-10/30/2003
600CVTX gets approvable letter: Message 19451536mopgcw-10/30/2003
599October short interest. The 25 issues requiring the highest number of days to cIcebrg-10/29/2003
598October short interest. The 25 issues with the highest percentage of the total Icebrg-10/29/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):